A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation
- 935 Downloads
Oral mucositis (OM) is a significant early complication of hematopoietic cell transplantation (HCT). This phase III randomized double-blind placebo-controlled study was designed to compare the ability of 2 different low level GaAlAs diode lasers (650 nm and 780 nm) to prevent oral mucositis in HCT patients conditioned with chemotherapy or chemoradiotherapy.
Materials and methods
Seventy patients were enrolled and randomized into 1 of 3 treatment groups: 650 nm laser, 780 nm laser or placebo. All active laser treatment patients received daily direct laser treatment to the lower labial mucosa, right and left buccal mucosa, lateral and ventral surfaces of the tongue, and floor of mouth with energy densities of 2 J/cm2. Study treatment began on the first day of conditioning and continued through day +2 post HCT. Mucositis and oral pain was measured on days 0, 4, 7, 11, 14, 18, and 21 post HCT.
The 650 nm wavelength reduced the severity of oral mucositis and pain scores. Low level laser therapy was well-tolerated and no adverse events were noted.
While these results are encouraging, further study is needed to truly establish the efficacy of this mucositis prevention strategy. Future research needs to determine the effects of modification of laser parameters (e.g., wavelength, fluence, repetition rate of energy delivery, etc.) on the effectiveness of LLE laser to prevent OM.
KeywordsLow level laser Mucositis prevention Hematopoietic cell transplant
- 15.Tardieu C, Cowen D, Thirion, X, Franquin JC (1996) Quantitative scale of oral mucositis associated with autologous bone marrow transplantation. Eur J Cancer 32:381–387Google Scholar
- 16.Epstein JB, Schubert MM (2003) Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology (Williston Park) 17:1767–1779 (discussion 1779–1782, 1791–1792)Google Scholar
- 18.Schubert MM, Franquin JC, Niccoli-Filho, Marical F, Lloid M, Kelly J (1997) Effects of low-energy laser on oral mucositis: a phase I/II pilot study. Cancer Res Wkly 7:14Google Scholar
- 22.Migliorati C, Massumoto C, Eduardo FP, Muller KP, Carrieri T, Haypek P et al (2001) Low-energy laser therapy in oral mucositis. Science 1:97–100Google Scholar
- 23.Bensadoun RJ, Ciais G (2002) Radiation and chemotherapy-induced mucositis in oncology: results of multicenter phase III studies. The Journal of Oral Laser Applications 2:115–120Google Scholar
- 31.Loevshall H, Arenholt-Bindslev D (1994) Effect of low level diode irradiation of human oral mucous fibroblasts in vitro. Lasers Surg Med 59:167–170Google Scholar